Ixekizumab (Anti-CTLA-8 / IL-17a)
Product Specifications
CAS Number
1143503-69-8
Synonyms
LY2439821
SKU
C00618-1mg
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Ixekizumab (Anti-CTLA-8 / IL-17a) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM) . Ixekizumab has the potential to be used in research on plaque psoriasis. MW: 146.44 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1242217-01 0.02 mg (E-Coli)
Recombinant Thermococcus sibiricus Aspartate carbamoyltransferase regulatory chain (pyrI)
Sign In for Pricing
View Details MBS1242217-02 0.1 mg (E-Coli)
Recombinant Thermococcus sibiricus Aspartate carbamoyltransferase regulatory chain (pyrI)
Sign In for Pricing
View Details 
MBS1242217-03 0.02 mg (Yeast)
Recombinant Thermococcus sibiricus Aspartate carbamoyltransferase regulatory chain (pyrI)
Sign In for Pricing
View Details